Clinical Trial Update: Study of CMP-CPS-001 in Healthy Volunteers and Participants With Abnormal Heterozygous OTC Genotype [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for CMP-CPS-001 in healthy volunteers and individuals with abnormal heterozygous OTC genotype; the study is active but not current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ornithine Transcarbamylase Deficiency

Drugs mentioned

• CMP-CPS-001

Snippet

Sponsor: CAMP4 Therapeutics Corporation | Conditions: Healthy Volunteers, OTC Deficiency | Phase 1 | Status: ACTIVE_NOT_RECRUITING